Select Medical (NYSE:SEM) Earns Buy Rating from Benchmark

Benchmark reaffirmed their buy rating on shares of Select Medical (NYSE:SEM) in a research note released on Friday morning, Benzinga reports. Benchmark currently has a $48.00 target price on the health services provider’s stock.

Separately, Bank of America initiated coverage on shares of Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $40.75.

Select Medical Price Performance

Shares of SEM stock opened at $36.51 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm’s 50-day moving average is $34.27 and its two-hundred day moving average is $34.14. Select Medical has a 12 month low of $21.28 and a 12 month high of $40.50. The company has a market capitalization of $4.73 billion, a PE ratio of 17.06, a price-to-earnings-growth ratio of 2.09 and a beta of 1.42.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm earned $0.46 earnings per share. Select Medical’s quarterly revenue was up 5.7% compared to the same quarter last year. Analysts predict that Select Medical will post 2.15 earnings per share for the current year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th will be given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Wednesday, November 13th. Select Medical’s dividend payout ratio is presently 23.36%.

Institutional Investors Weigh In On Select Medical

A number of institutional investors have recently made changes to their positions in SEM. Allspring Global Investments Holdings LLC increased its position in shares of Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock valued at $198,000 after acquiring an additional 405 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in shares of Select Medical by 26.1% in the first quarter. BNP Paribas Financial Markets now owns 55,543 shares of the health services provider’s stock valued at $1,675,000 after purchasing an additional 11,507 shares in the last quarter. Capstone Investment Advisors LLC acquired a new position in shares of Select Medical in the first quarter valued at approximately $690,000. Fidelis Capital Partners LLC acquired a new position in shares of Select Medical in the first quarter valued at approximately $47,000. Finally, Essex Investment Management Co. LLC grew its holdings in shares of Select Medical by 16.9% in the first quarter. Essex Investment Management Co. LLC now owns 156,574 shares of the health services provider’s stock valued at $4,721,000 after purchasing an additional 22,674 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.